Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma
Authors:
Open Access
- 27 February 2014
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 110 (8) , 2047-2053
Abstract
Background: On the basis of our recent findings of oncogenic KRAS-induced interleukin-8 (IL-8) overexpression in non-small cell lung cancer, we assessed the clinicopathological and prognostic significances of IL-8 expression and its relationship to KRAS mutations in lung adenocarcinomas. Methods: IL-8 expression was examined by quantitative RT–PCR using 136 of surgical specimens from lung adenocarcinoma patients. The association between IL-8 expression, clinicopathological features, KRAS or EGFR mutation status and survival was analysed. Results: IL-8 was highly expressed in tumours from elderly patients or smokers and in tumours with pleural involvement or vascular invasion. In a non-smokers’ subgroup, IL-8 level positively correlated with age. IL-8 was highly expressed in tumours with KRAS mutations compared with those with EGFR mutations or wild-type EGFR/KRAS. Lung adenocarcinoma patients with high IL-8 showed significantly shorter disease-free survival (DFS) and overall survival (OS) than those with low IL8. DFS and OS were significantly shorter in the patients with mutant KRAS/high IL-8 than in those with wild-type KRAS/low IL-8. Cox regression analyses demonstrated that elevated IL-8 expression correlated with unfavourable prognosis. Conclusions: Our findings suggest that IL-8 expression is associated with certain clinicopathological features including age and is a potent prognostic marker in lung adenocarcinoma, especially in oncogenic KRAS-driven adenocarcinoma.Keywords
This publication has 39 references indexed in Scilit:
- Targeting ROS1 with Anaplastic Lymphoma Kinase Inhibitors: A Promising Therapeutic Strategy for a Newly Defined Molecular Subset of Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2012
- Senescent cells as a source of inflammatory factors for tumor progressionCancer and Metastasis Reviews, 2010
- Angiogenesis in the Treatment of Non-Small Cell Lung CancerProceedings of the American Thoracic Society, 2009
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor SuppressorPLOS Biology, 2008
- Cellular Senescence in Cancer and AgingCell, 2007
- Interleukin-8 in non-small cell lung carcinoma: Relation with angiogenic pattern and p53 alterationsLung Cancer, 2005
- Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.2003
- Smoking and Airway Inflammation in Patients With Mild AsthmaChest, 2001
- Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome.1998
- Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.Journal of Clinical Investigation, 1996